Differential systemic exposure to galangin after oral and intravenous administration to rats
Open Access
- 31 March 2015
- journal article
- Published by Springer Nature in BMC Chemistry
- Vol. 9 (1) , 14
Abstract
Background: Galangin (3,5,7-trihydroxyflavone) is present in high concentrations in herbal medicine such as Alpinia officinarum Hance. Galangin shows multifaceted in vitro and in vivo biological activities. The number and position of hydroxyl groups in this molecule play an important role in these biological activities. However, these hydroxyl groups undergo glucuronidation and sulfation in in vitro assay system. However, the systemic exposure to galangin after dosing in animals and/or humans remains largely unknown. Thus it is not clear whether the galangin exists in the body at concentrations high enough for the biological effects. Furthermore, the metabolite identification and the corresponding plasma pharmacokinetics need to be characterized. Results: Two LC-MS/MS methods were developed and validated and successfully applied to analyze the parent drug molecules and aglycones liberated from plasma samples via β-glucuronidase hydrolysis. Our major findings were as follows: (1) The routes of administration showed significant influences on the systemic exposure of galangin and its metabolites. (2) Galangin was preferentially glucuronidated after p.o. dosing but sulfated after i.v. medication. (3) Kaempferol conjugates were detected demonstrating that oxidation reaction occurred; however, both glucuronidation and sulfation were more efficient. (4) Oral bioavailability of free parent galangin was very low. Conclusions: Systemic exposure to galangin and its metabolites was different in rat plasma between oral and intravenous administration. Further research is needed to characterize the structures of galangin conjugates and to evaluate the biological activities of these metabolites.Keywords
This publication has 30 references indexed in Scilit:
- Identification of known chemicals and their metabolites from Alpinia oxyphylla fruit extract in rat plasma using liquid chromatography/tandem mass spectrometry (LC–MS/MS) with selected reaction monitoringJournal of Pharmaceutical and Biomedical Analysis, 2014
- In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: Role of localization and intermolecular interaction in model membraneEuropean Journal of Medicinal Chemistry, 2014
- Flavonoid Bioavailability and Attempts for Bioavailability EnhancementNutrients, 2013
- Quantitative analysis of the major constituents in Chinese medicinal preparation SuoQuan formulae by ultra fast high performance liquid chromatography/quadrupole tandem mass spectrometryBMC Chemistry, 2013
- Quercetin-3-O-glucuronide affects the gene expression profile of M1 and M2a human macrophages exhibiting anti-inflammatory effectsFood & Function, 2012
- Multiple Peaking Phenomena in Pharmacokinetic DispositionClinical Pharmacokinetics, 2010
- The impact of flavonoids on memory: physiological and molecular considerationsChemical Society Reviews, 2009
- Macrophage as a Target of Quercetin Glucuronides in Human Atherosclerotic ArteriesJournal of Biological Chemistry, 2008
- Dietary Flavonoids Attenuate Tumor Necrosis Factor α-induced Adhesion Molecule Expression in Human Aortic Endothelial CellsJournal of Biological Chemistry, 2006
- Oxidation of the Flavonoids Galangin and Kaempferide by Human Liver Microsomes and CYP1A1, CYP1A2, and CYP2C9Drug Metabolism and Disposition, 2002